Jefferson researchers show melatonin's potential benefits in preventing Parkinson's damage

October 23, 1999

Melatonin could be a key to someday understanding how to treat Parkinson's disease. Scientists at Jefferson Medical College have shown in the laboratory and in test animals that melatonin is effective in preventing a particular type of brain cell damage similar to that found in Parkinson's.

Many researchers believe that the loss of dopamine nerve cells seen in Parkinson's disease patients' brains results from oxidative stress to the cells. Various cellular insults produce oxygen free-radicals, resulting in cell death. The brain's dopamine neurons are particularly vulnerable.

Melatonin, a hormone produced by the brain and which is marketed as an anti-aging agent commercially, is the body's most potent antioxidant. Two years ago, Lorraine Iacovitti, Ph.D., professor of neurology at Thomas Jefferson University in Philadelphia, and her co-workers showed in the laboratory that melatonin was effective in blocking the oxidative ravages of Parkinson's-damaged dopamine-producing cells.

Dr. Iacovitti and her team tested the theory in rats by giving the animals a toxin, 6-hydroxydopamine, which specifically damages dopamine neurons, producing a Parkinsonian-like syndrome. They found that by injecting melatonin into the rats either 10 minutes prior to the 6-hydroxy infusion or 30 minutes after, they could block the Parkinsonian effects. They were able to prevent about half of the damage, or "rescue the cells," if melatonin was given two hours later.

Dr. Iacovitti presents her team's findings October 24 at the annual meeting of the Society for Neuroscience in Miami Beach.

"If you get enough antioxidants to the dopamine nerve cells, you might be able to prevent the kinds of oxidative stress and cell death you see in Parkinson's," she says.

Dr. Iacovitti notes that melatonin "has the correct action to be developed pharmaceutically," but cautions that the dosages given to the test animals were extremely high. "Whether it could be developed into a drug is another question," she says. "It's difficult to know at what levels to keep antioxidants in the body." A drug company might be able to isolate an active part of melatonin that could be a more effective antioxidant at lower doses.

She continues to study other examples of toxin-induced Parkinsonism, some of which cause damage by other means.

She explains that in oxidative stress, cells don't automatically die. Rather, they pass through a cascade of cellular events leading to cell death. She and her team used melatonin to stop the cascade at its beginning. They would like to explore other checkpoints in the death cascade to gauge the compound's effectiveness.
-end-


Thomas Jefferson University

Related Brain Articles from Brightsurf:

Glioblastoma nanomedicine crosses into brain in mice, eradicates recurring brain cancer
A new synthetic protein nanoparticle capable of slipping past the nearly impermeable blood-brain barrier in mice could deliver cancer-killing drugs directly to malignant brain tumors, new research from the University of Michigan shows.

Children with asymptomatic brain bleeds as newborns show normal brain development at age 2
A study by UNC researchers finds that neurodevelopmental scores and gray matter volumes at age two years did not differ between children who had MRI-confirmed asymptomatic subdural hemorrhages when they were neonates, compared to children with no history of subdural hemorrhage.

New model of human brain 'conversations' could inform research on brain disease, cognition
A team of Indiana University neuroscientists has built a new model of human brain networks that sheds light on how the brain functions.

Human brain size gene triggers bigger brain in monkeys
Dresden and Japanese researchers show that a human-specific gene causes a larger neocortex in the common marmoset, a non-human primate.

Unique insight into development of the human brain: Model of the early embryonic brain
Stem cell researchers from the University of Copenhagen have designed a model of an early embryonic brain.

An optical brain-to-brain interface supports information exchange for locomotion control
Chinese researchers established an optical BtBI that supports rapid information transmission for precise locomotion control, thus providing a proof-of-principle demonstration of fast BtBI for real-time behavioral control.

Transplanting human nerve cells into a mouse brain reveals how they wire into brain circuits
A team of researchers led by Pierre Vanderhaeghen and Vincent Bonin (VIB-KU Leuven, Université libre de Bruxelles and NERF) showed how human nerve cells can develop at their own pace, and form highly precise connections with the surrounding mouse brain cells.

Brain scans reveal how the human brain compensates when one hemisphere is removed
Researchers studying six adults who had one of their brain hemispheres removed during childhood to reduce epileptic seizures found that the remaining half of the brain formed unusually strong connections between different functional brain networks, which potentially help the body to function as if the brain were intact.

Alcohol byproduct contributes to brain chemistry changes in specific brain regions
Study of mouse models provides clear implications for new targets to treat alcohol use disorder and fetal alcohol syndrome.

Scientists predict the areas of the brain to stimulate transitions between different brain states
Using a computer model of the brain, Gustavo Deco, director of the Center for Brain and Cognition, and Josephine Cruzat, a member of his team, together with a group of international collaborators, have developed an innovative method published in Proceedings of the National Academy of Sciences on Sept.

Read More: Brain News and Brain Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.